Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Sethi

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
Respiratory Medicine|April 20, 2026
Outcomes of Patients with COPD Before and After Initiation of Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate: Results from the US ARCTOS StudySanjay Sethi, Laurence Gozalo, Donna McMorrow, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterolSanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.
Annals of the American Thoracic Society|January 16, 2014
Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary diseaseHimanshu Desai, Karen Eschberger, Catherine Wrona, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2009
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profileGordon J Gaschler, Marko Skrtic, Caleb C J Zavitz, et al.
Respiratory Research|August 11, 2017
A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary diseasePeter M A Calverley, Sanjay Sethi, Michelle Dawson, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary DiseaseManoj J Mammen, Chengjian Tu, Matthew C Morris, et al.
Open Forum Infectious Diseases|January 30, 2020
Impact of <i>Pseudomonas aeruginosa</i> Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease CohortDavid M Jacobs, Heather M Ochs-Balcom, Katia Noyes, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2006
Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung diseaseCharles S Berenson, Catherine T Wrona, Lori J Grove, et al.
Science Translational Medicine|April 15, 2011
Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse modelChristopher J Harvey, Rajesh K Thimmulappa, Sanjay Sethi, et al.
Vaccine|August 25, 2009
Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidatesLaura A Novotny, Leanne D Adams, D Richard Kang, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Respiratory Medicine|April 20, 2026
Outcomes of Patients with COPD Before and After Initiation of Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate: Results from the US ARCTOS StudySanjay Sethi, Laurence Gozalo, Donna McMorrow, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterolSanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.
Annals of the American Thoracic Society|January 16, 2014
Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary diseaseHimanshu Desai, Karen Eschberger, Catherine Wrona, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2009
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profileGordon J Gaschler, Marko Skrtic, Caleb C J Zavitz, et al.
Respiratory Research|August 11, 2017
A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary diseasePeter M A Calverley, Sanjay Sethi, Michelle Dawson, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary DiseaseManoj J Mammen, Chengjian Tu, Matthew C Morris, et al.
Open Forum Infectious Diseases|January 30, 2020
Impact of <i>Pseudomonas aeruginosa</i> Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease CohortDavid M Jacobs, Heather M Ochs-Balcom, Katia Noyes, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2006
Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung diseaseCharles S Berenson, Catherine T Wrona, Lori J Grove, et al.
Science Translational Medicine|April 15, 2011
Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse modelChristopher J Harvey, Rajesh K Thimmulappa, Sanjay Sethi, et al.
Vaccine|August 25, 2009
Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidatesLaura A Novotny, Leanne D Adams, D Richard Kang, et al.
Pageof 21